EU Labs Bolster Detection of Rare Viruses
Reference laboratories are building member-state capacity for rare pathogens, a continuing effort already underway since 2025.
Updated on Nov. 5, 2026 in Life Sciences

EU reference laboratories have helped member states assess and strengthen their capacity to detect rare viruses, following recent outbreaks of Ebola and hantavirus. The support is ongoing work that the laboratories have run since 2025, and it is operational capacity-building rather than a new product or technology.
Why it matters
Detecting rare pathogens depends on national laboratories being able to run accurate diagnostics for agents they rarely see, and the EU network is working to close that gap before cases arrive. The effort follows Andes virus and Bundibugyo ebolavirus incidents, in which countries received diagnostic support before an affected ship reached EU shores.
The support combines reference diagnostics, reference materials, external quality assessments and scientific advice delivered through specialist EU Reference Laboratories. The stub gives no measured performance figures for the diagnostic tests themselves.
The players
European Centre for Disease Prevention and Control (ECDC)
The EU agency that monitors communicable disease threats and coordinates the public health response across member states, and issued the European Laboratory Day statement.
EU Reference Laboratory for Public Health on Emerging, Rodent-borne, and Zoonotic Viral Pathogens
An EU reference laboratory specializing in viruses that emerge or jump from animals to humans, which provided support in the recent rare-virus effort.
EU Reference Laboratory for Vector-Borne Viruses
An EU reference laboratory that focuses on viruses transmitted by insects and other vectors, and which provided backing for the effort.
The details
EU Reference Laboratories act as specialist hubs that support national reference laboratories in each member state. They supply reference diagnostics and materials, run external quality assessments that check whether labs are reading samples correctly, and provide training and help during outbreaks. For the Andes virus and Bundibugyo ebolavirus cases, a rapid assessment checked diagnostic capacity across member states, and support came from the Reference Laboratory for Public Health on Emerging, Rodent-borne, and Zoonotic Viral Pathogens and the Reference Laboratory for Vector-Borne Viruses.
Timeline
2025: Reference laboratories began strengthening rare-virus diagnostic capacity.
5 November: European Laboratory Day, when ECDC issued a statement recognizing laboratory professionals' work.
The Tech Race
The work sits within Europe's broader push to build laboratory capacity for communicable disease threats, a field where rapid and accurate diagnostics determine how quickly outbreaks are caught. The stub does not name a competing program or prior milestone against which this effort is directly benchmarked.
The work affects public health laboratories and the clinicians who depend on them, because accurate and fast diagnostics determine whether a rare infection is identified quickly. The stub gives no timeline for consumer-facing changes or new testing services available to the public.
The takeaway
The main trajectory is that European preparedness for rare pathogens increasingly rests on a standing network of reference laboratories rather than ad hoc responses. Watch for the results of the capacity assessment across member states, which would show whether the diagnostic gaps flagged by the Andes virus and Bundibugyo ebolavirus work have been closed.
Further reading
For background on how diagnostic work underpins pathogen tracking, see the Life Sciences section.
Source note: This article includes information reported by Brusselstimes.


